Ceftolozane/tazobactam treatment of multidrug-resistant pseudomonas aeruginosa infections in children

Leah Molloy, Ibrahim Abdulhamid, Ruma Srivastava, Jocelyn Y. Ang

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

The clinical use, safety and effectiveness of ceftolozane/tazobactam among 13 patients 3 months to 19 years of age infected with multidrug-resistant Pseudomonas aeruginosa are described. All but one patient achieved clinical cure after initial treatment. Adverse drug events attributed to treatment included transaminitis and neutropenia which occurred in 2 patients and resolved upon dose reduction.

Original languageEnglish
Pages (from-to)419-420
Number of pages2
JournalPediatric Infectious Disease Journal
DOIs
StateAccepted/In press - 2020

Keywords

  • Ceftolozane/tazobactam
  • Multidrug-resistant
  • Pseudomonas aeruginosa

Fingerprint

Dive into the research topics of 'Ceftolozane/tazobactam treatment of multidrug-resistant pseudomonas aeruginosa infections in children'. Together they form a unique fingerprint.

Cite this